Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Genetic toxicity: in vitro

Currently viewing:

Administrative data

Endpoint:
in vitro gene mutation study in bacteria
Type of information:
experimental study
Adequacy of study:
key study
Study period:
14 Sep - 02 Oct 2017
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
guideline study

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
2017
Report date:
2017

Materials and methods

Test guidelineopen allclose all
Qualifier:
according to guideline
Guideline:
OECD Guideline 471 (Bacterial Reverse Mutation Assay)
Version / remarks:
adopted in 1997
Deviations:
yes
Remarks:
2-AA is used as the sole indicator of the efficacy of the S9-mix
Qualifier:
according to guideline
Guideline:
EU Method B.13/14 (Mutagenicity - Reverse Mutation Test Using Bacteria)
Version / remarks:
adopted in 2008
GLP compliance:
yes (incl. QA statement)
Remarks:
Hess. Ministerium für Umwelt, Klimaschutz, Landwirtschaft und Verbraucherschutz, Wiesbaden, Germany
Type of assay:
bacterial reverse mutation assay

Test material

Constituent 1
Chemical structure
Reference substance name:
p-anisic acid
EC Number:
202-818-5
EC Name:
p-anisic acid
Cas Number:
100-09-4
Molecular formula:
C8H8O3
IUPAC Name:
4-methoxybenzoic acid

Method

Target gene:
his operon and trp operon
Species / strainopen allclose all
Species / strain / cell type:
S. typhimurium TA 1535, TA 1537, TA 98 and TA 100
Species / strain / cell type:
E. coli WP2 uvr A
Metabolic activation:
with and without
Metabolic activation system:
cofactor supplemented post-mitochondrial fraction (S9 mix), prepared from the livers of rats treated with phenobarbital/β-naphthoflavone
Test concentrations with justification for top dose:
Experiment I:
All strains: 3, 10, 100, 333, 1000, 2500 and 5000 µg/plate with and without metabolic activation

Experiment II:
Strain WP2 uvrA: 10, 33, 100, 333, 1000, 2500 and 5000 μg/plate
Samonella strains: 33, 100, 333, 1000, 2500 and 5000 μg/plate

The test item precipitated in the overlay agar in the test tubes from 2500 to 5000 μg/plate in experiment I and at 5000 μg/plate in experiment II. Precipitation of the test item in the overlay agar on the incubated agar plates was observed in experiment I at 5000 μg/plate. In experiment II no precipitation of the test item occurred up to the highest investigated dose. The undissolved particles had no influence on the data recording. The concentration of 5000 µg/plate was selected as highest dose as recommended by the OECD guideline.
Vehicle / solvent:
- Vehicle used: DMSO
- Justification for choice of solvent/vehicle: The solvent was chosen because of its solubility properties and its relative nontoxicity to the bacteria.
Controls
Untreated negative controls:
yes
Negative solvent / vehicle controls:
yes
True negative controls:
no
Positive controls:
yes
Positive control substance:
sodium azide
methylmethanesulfonate
other: 4-nitro-o-phenylene-diamine and 2-aminoanthracene
Details on test system and experimental conditions:
METHOD OF APPLICATION: in agar (plate incorporation); preincubation

DURATION
- Preincubation period: 60 min
- Exposure duration: 48 h

NUMBER OF REPLICATIONS: 3 replications each in 2 independent experiments

DETERMINATION OF CYTOTOXICITY
- Method: other: reduction in the number of spontaneous revertants or a clearing of the bacterial background lawn
Evaluation criteria:
A test item was considered as a mutagen if a biologically relevant increase in the number of revertants exceeding the threshold of twice (strains TA 98, TA 100, and WP2 uvrA) or threefold (strains TA 1535 and TA 1537) of the colony count of the corresponding solvent control is observed.
A dose dependent increase is considered biologically relevant if the threshold is exceeded at more than one concentration.
An increase exceeding the threshold at only one concentration is judged as biologically relevant if reproduced in an independent second experiment.
A dose dependent increase in the number of revertant colonies below the threshold is regarded as an indication of a mutagenic potential if reproduced in an independent second experiment. However, whenever the colony counts remain within the historical range of negative and solvent controls such an increase is not considered biologically relevant
Statistics:
Mean values and standard deviation were calculated.

Results and discussion

Test resultsopen allclose all
Key result
Species / strain:
S. typhimurium, other: TA 1535, TA 1537, TA 98, TA 100
Metabolic activation:
with and without
Genotoxicity:
negative
Cytotoxicity / choice of top concentrations:
no cytotoxicity nor precipitates, but tested up to recommended limit concentrations
Vehicle controls validity:
valid
Untreated negative controls validity:
valid
Positive controls validity:
valid
Key result
Species / strain:
E. coli WP2 uvr A
Metabolic activation:
with and without
Genotoxicity:
negative
Cytotoxicity / choice of top concentrations:
cytotoxicity
Remarks:
both experiments: 2500 and 5000 µg/plate
Vehicle controls validity:
valid
Untreated negative controls validity:
valid
Positive controls validity:
valid
Additional information on results:
TEST-SPECIFIC CONFOUNDING FACTORS
- Precipitation: The test item precipitated in the overlay agar in the test tubes from 2500 to 5000 μg/plate in experiment I and at 5000 μg/plate in experiment II. Precipitation of the test item in the overlay agar on the incubated agar plates was observed in experiment I at 5000 μg/plate. In experiment II no precipitation of the test item occurred up to the highest investigated dose. The undissolved particles had no influence on the data recording.

Any other information on results incl. tables

Table 2. Summary of Experiment 1

EXPERIMENT 1 (Plate Incorporation Test)

S9-Mix

Without

Test item (µg/plate)

TA 1535

TA 1537

TA 98

TA 100

WP2 uvrA

NC (DMSO)

10 ± 4

8 ± 2

29 ± 6

123 ± 22

35 ± 5

Untreated

8 ± 2

11 ± 2

24 ± 6

151 ± 18

33 ± 6

3

11 ± 2

10 ± 2

27 ± 10

122 ± 12

37 ± 9

10

10 ± 2

9 ± 2

25 ± 8

141 ± 10

33 ± 3

33

9 ± 2

8 ± 3

26 ± 4

137 ± 10

33 ± 2

100

12 ± 4

8 ± 3

25 ± 1

121 ± 11

29 ± 9

333

9 ± 2

9 ± 5

30 ± 8

138 ± 18

31 ± 1

1000

8 ± 3

13 ± 2

29 ± 9

140 ± 1

19 ± 5

2500

8 ± 1

7 ± 3

24 ± 4

132 ± 13

11 ± 1

5000

8 ± 3 P

5 ± 1 P

18 ± 4 P

114 ± 5 P

5 ± 1 P

NaN3
10 µg

1063 ± 138

 

 

2216 ± 61

 

4-NOPD
10

 

 

778 ± 63

 

 

4-NOPD
50

 

69 ± 5

 

 

 

MMS
2 µL

 

 

 

 

962 ± 7

S9-Mix

With

 

 

 

 

 

 

Test item (µg/plate)

TA 1535

TA 1537

TA 98

TA 100

WP2 uvrA

NC (DMSO)

14 ± 4

13 ± 3

35 ± 7

92 ± 12

57 ± 11

Untreated

12 ± 2

12 ± 1

40 ± 7

108 ± 12

47 ± 2

3

12 ± 4

13 ± 3

37 ± 9

101 ± 8

38 ± 6

10

14 ± 2

14 ± 3

42 ± 10

111 ± 8

46 ± 4

33

10 ± 3

15 ± 1

41 ± 11

114 ± 18

46 ± 5

100

13 ± 4

17 ± 1

37 ± 14

113 ± 9

49 ± 4

333

11 ± 1

19 ± 3

42 ± 6

89 ± 4

40 ± 5

1000

8 ± 2

18 ± 1

29 ± 7

105 ± 11

34 ± 4

2500

12 ± 3

20 ± 4

34 ± 2

112 ± 8

14 ± 5

5000

7 ± 2 P

18 ± 4 P

32 ± 2 P

112 ± 3 P

5 ± 1 P

2-AA
2.5

369 ± 32

117 ± 22

3863 ± 401

1419 ± 235

 

2-AA
10

 

 

 

 

466 ± 27

NC = Negative/Vehicle Control
P = Precipitate

 

Table 3: Summary of Experiment 2

EXPERIMENT 2 (Pre-incubation Test)

S9-Mix

Without

Test item (µg/plate)

TA 1535

TA 1537

TA 98

TA 100

WP2 uvrA

NC (DMSO)

9 ± 1

10 ± 5

14 ± 2 B M

170 ± 13

29 ± 5

Untreated

9 ± 5

9 ± 3

19 ± 3 B M

199 ± 11

42 ± 7

10

 

 

 

 

38 ± 12

33

10 ± 2

7 ± 3

15 ± 2 B M

160 ± 15

26 ± 3

100

10 ± 4

9 ± 1

16 ± 1 B M

148 ± 18

33 ± 5

333

13 ± 3

7 ± 4

12 ± 2 B M

165 ± 10

35 ± 1

1000

10 ± 5

8 ± 2

11 ± 3 B M

165 ± 8

27 ± 7

2500

11 ± 3

9 ± 4

13 ± 1 B M

164 ± 23

12 ± 3

5000

7 ± 3

6 ± 2

10 ± 2 B M

161 ± 7

6 ± 2

NaN3
10

1212 ± 118

 

 

2181 ± 31

 

 

4-NOPD
10

 

 

328 ± 11 B M

 

 

4-NOPD
50

 

82 ± 12

 

 

 

MMS
2 µL

 

 

 

 

836 ± 14

S9-Mix

With

 

 

 

 

 

 

Test item (µg/plate)

TA 1535

TA 1537

TA 98

TA 100

WP2 uvrA

NC (DMSO)

13 ± 2

13 ± 1

16 ± 1 B M

159 ± 22

48 ± 8

Untreated

12 ± 3

13 ± 3

13 ± 2 B M

207 ± 11

48 ± 5

10

 

 

 

 

46 ± 1

33

9 ± 2

14 ± 4

16 ± 2 B M

159 ± 17

43 ± 2

100

12 ± 3

11 ± 1

16 ± 2 B M

159 ± 10

42 ± 5

333

12 ± 5

14 ± 5

12 ± 3 B M

158 ± 5

40 ± 2

1000

13 ± 3

14 ± 5

14 ± 1 B M

154 ± 14

33 ± 6

2500

12 ± 3

15 ± 1

13 ± 4 B M

145 ± 4

13 ± 3

5000

11 ± 5

11 ± 4

8 ± 2 B M

136 ± 9

4 ± 2

2-AA
2.5

429 ± 32

116 ± 12

3939 ± 222 B M

3982 ± 399

 

2-AA
10

 

 

 

 

501 ± 5

 

NC = Negative/Vehicle control
B = Extensive bacterial growth
M = Manual count

Applicant's summary and conclusion

Conclusions:
The test item was tested for bacterial mutagenicity according to OECD 471, with S. typhimurium strains TA 1535, 1537, 98 and 100 as well as E. coli WP2 uvr A at concentration levels up to 5000 µg/plate with and without metabolic activation. Based on the results of the conducted study the test item did not exhibit mutagenic properties in bacterial cells.